Ethyl 8-bromo-3-methylimidazo[1,2-a]pyridine-2-carboxylate, 98%, 1g

Methyl 2-(2,5-dioxoimidazolidin-4-yl)acetate, 95.0%, 100mg

N-(4-propylphenyl)acetamide, 95+%, 5g

2-Amino-4-methyl-1-(2,4,6-trimethyl-phenyl)-1H-pyrrole-3-carbonitrile, 95.0%, 5g

2-Bromo-4-phenyl-nicotinic acid, 95.0%, 1g

2,2-Difluoro-2-pyridin-2-ylethaneamine, 95.0%, 5g

tert-Butyl 3-(2-ethoxy-2-oxoethyl)pyrrolidine-1-carboxylate, 95.0%, 25g

Tideglusib, 98.0%, 5g

Bismuth Subsalicylate, 97%, 500g

(2-Bromo-4-(trifluoromethyl)thiazol-5-yl)methanol, 95+%, 5g

7-Chloro-1-cyclopropyl-6-fluoro-2,3-dihydro-4(1H)-quinolinone, 95%, 250mg

(R)-7-Fluorochroman-4-amine hydrochloride, 95.0%, 250mg

(2S,3S,4R,5R,6R)-6-(Acetoxymethyl)-3-hydroxytetrahydro-2H-pyran-2,4,5-triyl triacetate, 95.0%, 25g